TY - JOUR
T1 - Analysis of ischemic neuronal injury in CaV2.1 channel α1 subunit mutant mice
AU - Tian, Xiaoli
AU - Zhou, Ying
AU - Gao, Linghan
AU - He, Guang
AU - Jiang, Weizhong
AU - Li, Weidong
AU - Takahashi, Eiki
N1 - Funding Information:
This work was supported by the China 973 project (2010CB529604), National Scientific Foundation of China (81271511 and 30900432), Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, “Shu Guang” Project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation, Shanghai Pujiang Program to WL and Grants-in-Aid for Scientific Research KAKENHI ( 22500396 ) to ET. The authors reported no biomedical financial interests or potential conflicts of interest.
PY - 2013/4/26
Y1 - 2013/4/26
N2 - We studied the physiological role of CaV2.1α1 in ischemic neuronal injury using mutants. Rolling Nagoya and leaner mouse brains showed similar CaV2.1α1 expression patterns. MCAO model showed more severe ischemic area in rolling Nagoya than in leaner mice. Higher [Ca2+]i was induced in rolling Nagoya than in leaner mice. When examining ischemic mechanisms, comparison of allelic variants was useful. One of the main instigators leading to cell death and brain damage following ischemia is Ca2+ dysregulation. Neuronal membrane depolarization results in the activation of voltage-gated Ca2+ (CaV) channels and intracellular Ca2+ influx. We investigated the physiological role of the CaV2.1 (P/Q-type) channel in ischemic neuronal injury using CaV2.1 channel α1 subunit mutant mice, rolling Nagoya and leaner mice. The in vivo ischemia model with a complete occlusion of the middle cerebral artery showed that the infarct area at 24h was significantly smaller in rolling Nagoya (27.1±3.5% of total brain volume) and leaner (20.1±3.5%) mice compared to wild-type (42.9±4.5%) mice. In an in vitro Ca2+ imaging study, oxygen-glucose deprivation using a hippocampal slice induced a significantly slower rate of increase in intracellular Ca2+ concentration ([Ca2+]i) in rolling Nagoya (0.083±0.007/min) and leaner (0.062±0.006/min) mice compared to wild-type (0.105±0.008/min) mice. These results demonstrate that the mutant CaV2.1 channel in rolling Nagoya and leaner mice plays a different protective role in a ([Ca2+]i)-dependent manner in ischemic models and indicate that CaV2.1 channel blockers may be used preventively against ischemic injury.
AB - We studied the physiological role of CaV2.1α1 in ischemic neuronal injury using mutants. Rolling Nagoya and leaner mouse brains showed similar CaV2.1α1 expression patterns. MCAO model showed more severe ischemic area in rolling Nagoya than in leaner mice. Higher [Ca2+]i was induced in rolling Nagoya than in leaner mice. When examining ischemic mechanisms, comparison of allelic variants was useful. One of the main instigators leading to cell death and brain damage following ischemia is Ca2+ dysregulation. Neuronal membrane depolarization results in the activation of voltage-gated Ca2+ (CaV) channels and intracellular Ca2+ influx. We investigated the physiological role of the CaV2.1 (P/Q-type) channel in ischemic neuronal injury using CaV2.1 channel α1 subunit mutant mice, rolling Nagoya and leaner mice. The in vivo ischemia model with a complete occlusion of the middle cerebral artery showed that the infarct area at 24h was significantly smaller in rolling Nagoya (27.1±3.5% of total brain volume) and leaner (20.1±3.5%) mice compared to wild-type (42.9±4.5%) mice. In an in vitro Ca2+ imaging study, oxygen-glucose deprivation using a hippocampal slice induced a significantly slower rate of increase in intracellular Ca2+ concentration ([Ca2+]i) in rolling Nagoya (0.083±0.007/min) and leaner (0.062±0.006/min) mice compared to wild-type (0.105±0.008/min) mice. These results demonstrate that the mutant CaV2.1 channel in rolling Nagoya and leaner mice plays a different protective role in a ([Ca2+]i)-dependent manner in ischemic models and indicate that CaV2.1 channel blockers may be used preventively against ischemic injury.
UR - http://www.scopus.com/inward/record.url?scp=84876790748&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876790748&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2013.03.066
DO - 10.1016/j.bbrc.2013.03.066
M3 - Article
C2 - 23545255
AN - SCOPUS:84876790748
SN - 0006-291X
VL - 434
SP - 60
EP - 64
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -